HCA Inc. (HCA) - Forward P/S Multiple

Brandmark of HCA Holdings (HCA)

HCA Healthcare, Inc. (HCA) leads the US market through professional management and strict cost control. The company's forward P/S reflects the business valuation dynamics, where the value of 1.40 characterizes this level. Efficiency is enhanced by outsourcing service functions to external contractors. The operator's high status is based on patient trust and the application of advanced medical standards.

HCA Inc. - HCA Forward P/S Multiple (period 07/04/2022 - 11/17/2026)

Analytical breakdowns for HCA Healthcare (HCA)

- current price and projected stock value:
Summary company analysis:HCA Healthcare HCA
Manufactured products of hcahealthcare.com

This indicator determines the market value of a business relative to its expected future sales volume. By analyzing the forward price-to-sales ratio, an investor can see how many dollars of market capitalization the market is willing to pay per unit of future revenue. For HCA Healthcare, Inc. (HCA), this multiple reflects market confidence in the stable demand for healthcare and the cost-management efficiency of the largest hospital network in the US.

Competitors of HCA Healthcare, Inc. (HCA)

Tenet Healthcare Corporation - Forward Price-to-Revenue Multiple|Fresenius Medical (FMS) - Market Cap to Future Revenue Ratio|Solventum Corp - Forward P/S Multiple|Future Price to Revenue EHC|Universal Health Services (UHS) - Price-to-Projected Revenue Ratio|DaVita - Forward Price to Sales|Forward Price-to-Revenue Multiple RDNT|OPCH: Forward Price to Sales|Forward Price-to-Revenue Multiple SGRY (Surgery Partners, Inc.)|PINC (Premier, Inc.) - Forward Price to Sales|National Vision - Forward Price-to-Revenue Multiple|Market Cap to Expected Sales Ratio Progyny Inc (PGNY)|Ardent Health - Forward P/S Multiple|Market Cap to Expected Sales Ratio Select Medical Corp SEM|ASTH: Forward P/S Multiple|Market Cap to Projected Revenue MD|USPH (US Physical Therapy Inc) - Forward P/S Multiple|PNTG: Forward Price to Sales|Price-to-Projected Revenue Ratio Organogenesis Corp (ORGO)|NUTX (Nutex Health Corp) - Forward Price to Sales|Forward P/S Multiple AUNA (Auna S.A.)|SBC Medical Group Holdings Inc (SBC) - Market Cap to Future Revenue Ratio|EOLS - Price-to-Projected Revenue Ratio|Forward Price to Sales CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Forward Price-to-Revenue Multiple|Market Cap to Projected Revenue MDWD|Price-to-Projected Revenue Ratio biote Corp.|Market Cap to Future Revenue Ratio thejoint.com JYNT|Forward P/S Multiple DCGO|Forward Price-to-Revenue Multiple P3 Health PIII|Forward P/S Multiple GANX (Gain Therapeutics Inc.)|Forward P/S Multiple EUDA Health Holdings Limited EUDA|baselmedical.com - Forward P/S Multiple|CLGN: Price-to-Projected Revenue Ratio|Cuprina Holdings (Cayman) Ltd. (CUPR) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Concord Medical|AMS (American Shared Hospital Services Inc) - Forward P/S Multiple|MEDIROM Corp (MRM) - Market Cap to Expected Sales Ratio|Forward P/S Multiple ALBT|Market Cap to Expected Sales Ratio DIH Holding|Forward P/S Multiple XAGE (carmellcosmetics.com)|NIVF: Market Cap to Projected Revenue|ATIP: Forward Price-to-Revenue Multiple|CareMax Medical Group - Price to Expected Revenue Ratio|Kindly MD (KDLY) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue MODV|Price-to-Projected Revenue Ratio Novo Integrated Sciences Corp|Market Cap to Future Revenue Ratio SunLink Health Systems SSY|Price-to-Projected Revenue Ratio IMAC Corp (BACK)